title: Journal withdraws article after complaints from drug manufacturers.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004345:Drug Industry; D035081:Editorial Policies; D000077270:Exenatide; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D054795:Incretins / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced*; D010455:Peptides / Q000009:adverse effects*; D010506:Periodicals as Topic; D011719:Pyrazines / Q000009:adverse effects*; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000009:adverse effects*; D014688:Venoms / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D054795:Incretins; D010455:Peptides; D011719:Pyrazines; D014230:Triazoles; D014688:Venoms; D000077270:Exenatide; D000068900:Sitagliptin Phosphate